Matthew J. Hart, Ph.D. is an assistant professor of research in the Department of Biochemistry at the University of Texas Health Science Center San Antonio. Dr. Hart has a broad background in biochemistry, signal transduction and high throughput screening both in academic and pharmaceutical settings. His research is focused on the study of signaling pathways involved in pathological conditions such as cancer, aging and neurodegenerative diseases. In collaboration with Doug Frantz and Stan McHardy at University of Texas at San Antonio and Bruce Nicholson at the Health Science Center, Dr. Hart established the Center for Innovation in Drug Discovery (CIDD) which is a joint-venture between UTSA and the Health Science Center to provide capabilities and core services in drug discovery and drug development. Dr. Hart has a strong background in cancer signaling pathways, having made significant contributions to the field of GTPase regulation and beta-catenin biology. He currently serves as Director of the High Throughput Screening Facility at CIDD.